Acumetis, a new global company for the life sciences industry, has launched, It was formed by joining five expert consulting firms: Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group. The company helps life sciences businesses plan and sell their products at all stages of development.
Acumetis works as one team with a single leadership group, combining commercial, medical, insights, market access, and patient strategies in one place. It provides tools and data to help clients from planning and market access to launching products and tracking performance.
The company’s name shows its approach: ‘Acumen’ means good judgment, and ‘Metis,’ a Greek idea, means practical wisdom. Together, they represent a way of working that focuses on careful analysis, teamwork, and real results for clients.
According to coherent market insights, the Life Sciences Analytics Market is expected to grow at a CAGR of 12.5% from 2026 to 2033. Currently, the market is at USD 44.42 Bn in 2025 and is expected to be around USD 95.10 Bn by 2033. The global life sciences analytics market is experiencing strong growth due to the rising adoption of analytics solutions in pharmaceuticals & clinical trials and emergence of advanced analytics method in life science companies.
Acumetis, now combined into one company, will have over 350 experts working around the world and experience in more than 50 countries. The company already works with over 150 life sciences organizations, including many of the top global pharmaceutical companies. The original firms have helped launch more than 200 products and have many years of experience in bringing products to market.
The company is supported by DFW Capital, a private equity firm that invests in businesses providing services in regulated industries like healthcare and compliance.
Brent Herspiegel, CEO of Acumetis, said: "Acumetis is designed to set a new standard in commercialization. Not just in capability, but in how that capability is delivered. For over two decades, the businesses that form Acumetis have supported more than 200 product launches for some of the most complex and high-stakes assets in life sciences. We’re now bringing our clients our full expertise as one integrated brand, helping them to make the right decision at the moments that matter most. For life sciences companies facing compressed timelines, increasing regulatory complexity and rising pressure to demonstrate value, this is a compelling value proposition.”
Source
Press Release: Acumetis
Company: Acumetis
